// App-Quantinova.ai

P-122 : Optimising IUI; a systematic review and network meta-analysis

Researchers

Presenter

  • E Chronopoulou

Principal Investigators

  • S Shaikh

  • A Gaetano-Gil

  • C Raperport

  • K Tsiveriotis

  • B.H Al Wattar

  • J Zamora

  • P Bhide

Medical Centers

  • General University Hospital of Patras, Obstetrics and Gynaecology- Fetal Medicine, Patras, Greece

  • Hospital Universitario Ramón y Cajal IRYCIS- Clinical Biostatistics Unit, Clinical Biostatistics, Madrid, Spain

  • Clinical Biostatistics Unit- Hospital Universitario Ramón y Cajal IRYCIS- CIBER Epidemiology and Public Health CIBERESP- Women's Health Research Unit- Queen Mary University of London, Clinical Biostatistics, Madrid, Spain

  • Institute for Womens Health- University College London- Women's Health Department- University College London Hospitals, Women's Health, London, United Kingdom

  • London North West University Healthcare NHS Trust- Queen Mary University of London, Obstetrics and Gynaecology, London, United Kingdom

  • Homerton University Hospital- Queen Mary University of London, Fertility and Assisted Reproduction, London, United Kingdom

  • CREATE Fertility, Fertility and Assisted Reproduction, London, United Kingdom

  • CRGH- The Centre for Reproductive & Genetic Health, Fertility and Assisted Reproduction, London, United Kingdom

Locations

  • Greece

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Human chorionic gonadotropin

Drug/Treatment

  • Misoprostol

  • Cytotec

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A